This was again opposite to that PAK4KO promoted ICAM-1 and VCAM-1 expression and vascular normalisation in a syngeneic mouse model, suggesting the PAK4KO-stimulated anti-tumour immunity may contribute to its effect on vascular normalisation [30]. The gene discussed is VCAM1; the disease is neoplasm.